Diagnostic Kit SARS-cCo V Antigen Rapid Test — FDA record Z-1050-2022

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Apr 4, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Diagnostic Kit SARS-cCo V Antigen Rapid Test
Reason
COVID-19/SARS-CoV-2 Antigen Tests did not receive FDA Emergency Use Authorization, nor were the tests cleared or approved to be commercially distributed.
Classification
Class II
Recalling firm
USA Medical, LLC
Quantity
2055 kits
Agency-reported status
Ongoing
Source record identifier
Z-1050-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityCatalog/Model/Part Number: None UDI Code: None Lot Numbers: Unknown/None

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

U.S. Nationwide distribution in the states of CA, FL, IN, MD, MO, NJ, OK, and TN.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
May 18, 2022
Recall initiation date
Apr 4, 2022
Center classification date
May 6, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records